Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

TY - JOUR

T1 - Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

AU - Frerichs, Kristine A

AU - Bosman, Patricia W C

AU - van Velzen, Jeroen F

AU - Fraaij, Pieter L A

AU - Koopmans, Marion P G

AU - Rimmelzwaan, Guus F

AU - Nijhof, Inger S

AU - Bloem, Andries C

AU - Mutis, Tuna

AU - Zweegman, Sonja

AU - van de Donk, Niels W C J

N1 - Funding Information: 1Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam; 2University Medical Center, Laboratory of Translational Immunology, Utrecht and 3Erasmus Medical Center, Department of Viroscience, National Influenza Center, Rotterdam, the Netherlands. °Current address: University of Veterinary Medicine, Center for Emerging Infections and Zoonoses, Hannover, Germany Funding: the DARA/ATRA study was supported by research funding from Janssen Pharmaceuticals. Correspondence: Niels W.C.J. van de Donk n.vandedonk@amsterdamumc.nl doi:10.3324/haematol.2019.231860 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85085714907&partnerID=8YFLogxK

U2 - https://doi.org/10.3324/haematol.2019.231860

DO - https://doi.org/10.3324/haematol.2019.231860

M3 - Letter

C2 - 31558675

SN - 0390-6078

VL - 105

SP - E302-E306

JO - Haematologica

JF - Haematologica

IS - 6

M1 - e302-e306

ER -